相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An assessment of GLOBOCAN methods for deriving national estimates of cancer incidence
Sebastien Antoni et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2016)
The anticancer natural product ophiobolin A induces cytotoxicity by covalent modification of phosphatidylethanolamine
Christopher Chidley et al.
ELIFE (2016)
Angiogenesis Inhibitors for the Treatment of Hepatocellular Carcinoma
Massimiliano Berretta et al.
FRONTIERS IN PHARMACOLOGY (2016)
PE and PS Lipids Synergistically Enhance Membrane Poration by a Peptide with Anticancer Properties
Natalia Bueno Leite et al.
BIOPHYSICAL JOURNAL (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Anticancer and Toxic Properties of Cyclotides are Dependent on Phosphatidylethanolamine Phospholipid Targeting
Sonia Troeira Henriques et al.
CHEMBIOCHEM (2014)
Wilms' Tumor Gene 1 (WT1) Silencing Inhibits Proliferation of Malignant Peripheral Nerve Sheath Tumor sNF96.2 Cell Line
Rosalba Parenti et al.
PLOS ONE (2014)
Phosphatidylethanolamine Binding Is a Conserved Feature of Cyclotide-Membrane Interactions
Sonia Troeira Henriques et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Cyclotides Insert into Lipid Bilayers to Form Membrane Pores and Destabilize the Membrane through Hydrophobic and Phosphoethanolamine-specific Interactions
Conan K. Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Defective cell cycle checkpoints as targets for anti-cancer therapies
Brian Gabrielli et al.
FRONTIERS IN PHARMACOLOGY (2012)
Intra-tumour heterogeneity: a looking glass for cancer?
Andriy Marusyk et al.
NATURE REVIEWS CANCER (2012)
Lantibiotics as probes for phosphatidylethanolamine
Ming Zhao
AMINO ACIDS (2011)
Lipid-protein interactions
Anthony G. Lee
BIOCHEMICAL SOCIETY TRANSACTIONS (2011)
Principles and Current Strategies for Targeting Autophagy for Cancer Treatment
Ravi K. Amaravadi et al.
CLINICAL CANCER RESEARCH (2011)
Decoding the Membrane Activity of the Cyclotide Kalata B1 THE IMPORTANCE OF PHOSPHATIDYLETHANOLAMINE PHOSPHOLIPIDS AND LIPID ORGANIZATION ON HEMOLYTIC AND ANTI-HIV ACTIVITIES
Sonia Troeira Henriques et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Resistance to cancer treatment: the role of somatic genetic events and the challenges for targeted therapies
Gerald Batist et al.
FRONTIERS IN PHARMACOLOGY (2011)
Increased Exposure of Phosphatidylethanolamine on the Surface of Tumor Vascular Endothelium
Jason H. Stafford et al.
NEOPLASIA (2011)
Targeting Phosphatidylserine in Anti-Cancer Therapy
Heidi Kenis et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Targeted cancer therapy: Conferring specificity to cytotoxic drugs
Ravi V. J. Chari
ACCOUNTS OF CHEMICAL RESEARCH (2008)
Thematic review series: Glycerolipids. Phosphatidylserine and phosphatidylethanolamine in mammalian cells: two metabolically related aminophospholipids
Jean E. Vance
JOURNAL OF LIPID RESEARCH (2008)
99mTc-labeled duramycin as a novel phosphatidylethanolamine-binding molecular probe
Ming Zhao et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Computer-aided drug design: Integration of structure-based and ligand-based approaches in drug design
Philip Prathipati et al.
CURRENT COMPUTER-AIDED DRUG DESIGN (2007)
Curvature-dependent recognition of ethanolamine phospholipids by duramycin and cinnamycin
Kunihiko Iwamoto et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2007)
Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy
Fabio Pastorino et al.
CANCER RESEARCH (2006)
Placental thrombosis and spontaneous fetal death in mice deficient in ethanolamine kinase 2
Yong Tian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models
Dmitri B. Kirpotin et al.
CANCER RESEARCH (2006)
Membrane-lipid therapy: a new approach in molecular medicine
PV Escriba
TRENDS IN MOLECULAR MEDICINE (2006)
Multidrug resistance: Retrospect and prospects in anti-cancer drug treatment
Ricardo Perez-Tomas
CURRENT MEDICINAL CHEMISTRY (2006)
Comparing antibody and small-molecule therapies for cancer
Kohzoh Imai et al.
NATURE REVIEWS CANCER (2006)
Drug delivery systems: Entering the mainstream
TM Allen et al.
SCIENCE (2004)
The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies
G Morgan et al.
CLINICAL ONCOLOGY (2004)
Targeting protein kinases
I Melnikova et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
How lipids affect the activities of integral membrane proteins
AG Lee
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2004)
Cinnamycin (Ro 09-0198) promotes cell binding and toxicity by inducing transbilayer lipid movement
A Makino et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Vascular permeability factor/vascular endothelial growth factor: A critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy
HF Dvorak
JOURNAL OF CLINICAL ONCOLOGY (2002)
Converting a peptide into a drug: Strategies to improve stability and bioavailability
C Adessi et al.
CURRENT MEDICINAL CHEMISTRY (2002)
Multidrug resistance in cancer: Role of ATP-dependent transporters
MM Gottesman et al.
NATURE REVIEWS CANCER (2002)
Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis
MS Pepper
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
分享论文
